Drugs / TC-2216
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00583544 | Jan 2007 → Jan 2008 | — | Targacept Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TC-2216 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00583544 ↗ |
| Modality | Small molecule | — CHEMBL504652 ↗ |